MedTrace Logo

Cognitive Effects of Citicoline on Attention in Healthy Mean and Women

NCT04967157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2025-04-06

No results posted yet for this study

Summary

The objective of this trial is to determine the effects of citicoline on cognitive performance for attention in healrhy Men and Women compared to a placebo.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo supplement

Cellulose

DIETARY_SUPPLEMENT

Citicoline supplement

Cognizin ®

Sponsors & Collaborators

  • Biofortis Clinical Research, Inc.

    collaborator INDUSTRY

  • Kirin Holdings Company, Limited

    lead INDUSTRY

Principal Investigators

  • Kathleen Kelley, MD · Biofortis Clinical Research, Inc. Addison, Illinois, United States, 60101

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-08
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04967157 on ClinicalTrials.gov